Penumbra Inc (PEN)
$262.28 -10.96 (-4.01%)Market Cap | 10.68B |
Revenue (ttm) | 1.19B |
Net Income (ttm) | 14.01M |
EPS (ttm) | N/A |
PE Ratio | 94.47 |
Forward PE | 74.45 |
Profit Margin | 1.17% |
Debt to Equity Ratio | 0.00 |
Volume | 576,800 |
Avg Vol | 474,954 |
Day's Range | N/A - N/A |
Shares Out | 38.52M |
Stochastic %K | 41% |
Beta | 0.56 |
Analysts | Strong Sell |
Price Target | $308.06 |
Latest News on PEN

Apr 3, 2025, 4:30 PM EDT - 2 days ago
Penumbra, Inc. Schedules First Quarter 2025 Earnings Release and Conference Call for April 23, 2025


Feb 21, 2025, 4:05 PM EST - 6 weeks ago
Penumbra, Inc. Announces Don Kassing will Retire from Board of Directors

Feb 19, 2025, 4:03 PM EST - 6 weeks ago
Stroke Device Maker Penumbra Stock Surges On Earnings Beat, Analysts Boost Price Forecasts After Upbeat 2025 Outlook

Feb 18, 2025, 4:05 PM EST - 6 weeks ago
Penumbra, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results

Jan 21, 2025, 4:30 PM EST - 2 months ago
Penumbra, Inc. Schedules Fourth Quarter and Full Year 2024 Earnings Release and Conference Call for February 18, 2025

Dec 30, 2024, 4:30 PM EST - 3 months ago
Penumbra, Inc. to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Dec 17, 2024, 11:03 AM EST - 3 months ago
Penumbra Is Poised For Growth As Blood Clot Awareness Rises: Analyst

Nov 20, 2024, 4:30 PM EST - 4 months ago
Penumbra, Inc. to Present at the Piper Sandler 36th Annual Healthcare Conference


Oct 30, 2024, 4:05 PM EDT - 5 months ago
Penumbra, Inc. Reports Third Quarter 2024 Financial Results

Oct 14, 2024, 9:00 AM EDT - 6 months ago
Penumbra, Inc. Announces Completion of THUNDER IDE Study Enrollment for Acute Ischemic Stroke

Oct 2, 2024, 4:30 PM EDT - 6 months ago
Penumbra, Inc. Schedules Third Quarter 2024 Earnings Release and Conference Call for October 30, 2024

Sep 16, 2024, 3:00 AM EDT - 7 months ago
Penumbra Receives CE Mark for Computer Assisted Vacuum Thrombectomy Technologies - Lightning Flash™ 2.0 and Lightning Bolt™ 7 - in Europe

Aug 27, 2024, 4:30 PM EDT - 7 months ago
Penumbra, Inc. to Present at the Baird Global Healthcare Conference

Aug 21, 2024, 4:30 PM EDT - 8 months ago
Penumbra, Inc. to Present at the Wells Fargo Healthcare Conference

Aug 19, 2024, 9:28 PM EDT - 8 months ago
Penumbra: Growth In Its Thrombectomy Portfolio Should Lead To Strong Earnings

Aug 13, 2024, 7:00 AM EDT - 8 months ago
Penumbra, Inc. Announces $200 Million Share Repurchase Authorization

Aug 2, 2024, 4:30 PM EDT - 8 months ago
Penumbra, Inc. to Present at the Canaccord Genuity Growth Conference

Jul 30, 2024, 4:05 PM EDT - 8 months ago
Penumbra, Inc. Reports Second Quarter 2024 Financial Results

Jul 2, 2024, 4:05 PM EDT - 9 months ago
Penumbra, Inc. Schedules Second Quarter 2024 Earnings Release and Conference Call for July 30, 2024

Jun 4, 2024, 4:30 PM EDT - 10 months ago
Penumbra, Inc. to Present at the Truist Securities MedTech Conference

May 23, 2024, 4:30 PM EDT - 11 months ago
Penumbra, Inc. to Present at the William Blair Growth Stock Conference

May 7, 2024, 4:05 PM EDT - 11 months ago
Penumbra, Inc. Reports First Quarter 2024 Financial Results

May 1, 2024, 4:05 PM EDT - 1 year ago
Penumbra, Inc. to Present at the RBC Capital Markets Global Healthcare Conference

Apr 23, 2024, 9:00 AM EDT - 1 year ago
Penumbra Launches Lightning Flash 2.0 - Latest CAVT Technology Designed to Rapidly Remove Blood Clots

Apr 9, 2024, 4:05 PM EDT - 1 year ago
Penumbra, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call for May 7, 2024

Feb 22, 2024, 4:05 PM EST - 1 year ago
Penumbra, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results

Feb 1, 2024, 4:05 PM EST - 1 year ago
Penumbra, Inc. Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call for February 22, 2024

Dec 18, 2023, 7:50 PM EST - 1 year ago
Penumbra, Inc. to Present at the J.P. Morgan 42nd Annual Healthcare Conference


Nov 14, 2023, 4:05 PM EST - 1 year ago
Penumbra, Inc. to Present at the Piper Sandler 35th Annual Healthcare Conference

Nov 10, 2023, 5:43 PM EST - 1 year ago
Penumbra Teams Up with Honor Everywhere to Bring US War Memorials to Aging Veterans

Nov 1, 2023, 4:05 PM EDT - 1 year ago
NEW LATE BREAKING DATA DEMONSTRATE PENUMBRA'S COMPUTER ASSISTED VACUUM THROMBECTOMY TECHNOLOGY FOR PULMONARY EMBOLISM IMPROVED PATIENT OUTCOMES


Oct 5, 2023, 4:05 PM EDT - 1 year ago
Penumbra, Inc. Schedules Third Quarter 2023 Earnings Release and Conference Call for November 2, 2023